Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
Compare Profit and Loss Results of Jenburkt Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
168.00
368.00
-200.00
-54.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
168.00
333.00
-165.00
-49.55%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
4.00
-8.00
-200.00%
Raw Materials Consumed
37.00
164.00
-127.00
-77.44%
Power & Fuel Cost
0.00
27.00
-27.00
-100.00%
Employee Cost
49.00
45.00
4.00
8.89%
Operating Expenses
4.00
28.00
-24.00
-85.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
19.00
4.00
15.00
375.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
125.00
289.00
-164.00
-56.75%
Operating Profit (PBDIT) excl Other Income
43.00
44.00
-1.00
-2.27%
Other Income
10.00
3.00
7.00
233.33%
Operating Profit (PBDIT)
54.00
48.00
6.00
12.50%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
53.00
40.00
13.00
32.50%
Depreciation
3.00
10.00
-7.00
-70.00%
Profit Before Taxation & Exceptional Items
50.00
30.00
20.00
66.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
30.00
16.00
53.33%
Provision for Tax
11.00
8.00
3.00
37.50%
Profit After Tax
34.00
21.00
13.00
61.90%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
162.00
101.00
61.00
60.40%
Profit Available for appropriations
197.00
122.00
75.00
61.48%
Appropriations
197.00
122.00
75.00
61.48%
Equity Dividend (%)
207%
15%
192.00
Earnings Per Share
78.71
70.69
8.02
11.35%
Profit And Loss - Net Sales
Net Sales 168.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Profit And Loss - Interest
Interest 0.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 34.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
